How much funding has Aspen Neuroscience raised?

Aspen Neuroscience has raised $339.0M in total funding, most recently a Series C round.

Who are Aspen Neuroscience's investors?

Aspen Neuroscience's investors include ARCH Venture Partners, OrbiMed, Revelation Partners, Domain Associates, Frazier Life Sciences, GV.

When was Aspen Neuroscience founded?

Aspen Neuroscience was founded in 2018.

Where is Aspen Neuroscience headquartered?

Aspen Neuroscience is headquartered in San Diego, California, United States.

What industry is Aspen Neuroscience in?

Aspen Neuroscience operates in Biotech, Healthcare, Therapeutics.

How many employees does Aspen Neuroscience have?

Aspen Neuroscience has 51-200 employees.

Aspen Neuroscience

Personalized medicine begins with you

San Diego, United States · Founded 2018 · $339.0M raised

Biotech

Healthcare

Therapeutics

Headquarters: San Diego, California
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: aspenneuroscience.com
Total Funding: $339.0M
Last Round: $115.0M Series CNov 2025
Rounds: 4

About

Aspen Neuroscience is a clinical-stage biotech developing ANPD001, the world's first autologous iPSC-derived neuron replacement therapy for Parkinson's disease. Using a patient's own skin cells reprogrammed into dopamine-producing neurons, the treatment eliminates immunosuppression requirements and is currently in Phase 1/2a clinical trials.

Summary

Aspen Neuroscience is a Biotech company based in San Diego, United States, founded in 2018. It has raised $339.0M in total across 4 rounds, most recently a $115.0M Series C round in Nov 2025. Investors include ARCH Venture Partners, OrbiMed and Revelation Partners.

LinkedIn X (Twitter)